Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-10 5:52 pm Purchase | 2024-04-30 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | RA Capital Management, L.P. | 7,714,760 9.990% | 7,714,760 (New Position) | Filing History |
| 2024-02-21 8:26 pm Purchase | 2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | Merchant Fahar | 20,244,255 29.100% | 1,704,223 (+9.19%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 4,672,075 6.700% | 242,092 (+5.46%) | Filing History |
| 2023-02-15 06:35 am Purchase | 2022-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 4,429,983 6.400% | 516,829 (+13.21%) | Filing History |
| 2023-02-14 2:30 pm Purchase | 2022-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | Merchant Fahar | 18,540,032 25.700% | 365,664 (+2.01%) | Filing History |
| 2022-10-20 06:02 am Purchase | 2022-08-10 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 3,913,154 5.600% | 3,913,154 (New Position) | Filing History |
| 2022-02-10 2:48 pm Purchase | 2021-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | Merchant Fahar | 18,174,368 31.500% | 239,368 (+1.33%) | Filing History |
| 2021-02-12 4:24 pm Purchase | 2020-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | Merchant Fahar | 17,935,000 32.700% | 17,935,000 (New Position) | Filing History |